ResearcherFudan UniversityActive in the last 2 years

Xuesong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-5373-7941; OpenAlex author ID A5100449088. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression. Co-author DOI 10.1016/j.cyto.2023.156451 ↗
LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer. Co-author DOI 10.2217/fon-2019-0321 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weiwei Jiang · 1 shared paper, 2024 · strength 0.24
- Paper Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expressio… DOI 10.1016/j.cyto.2023.156451 ↗
Yi Yu · 1 shared paper, 2019 · strength 0.11
- Paper LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer. DOI 10.2217/fon-2019-0321 ↗
Yuan Yu · 1 shared paper, 2019 · strength 0.11
- Paper LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer. DOI 10.2217/fon-2019-0321 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.